Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GlaxoSmithKline Integrates Cancer Discovery, Development In “GSK Oncology” Unit

This article was originally published in The Pink Sheet Daily

Executive Summary

The move mirrors actions of other major pharmas, such as Pfizer and Novartis.
Advertisement

Related Content

GSK’s Witty Looks To Biotech Model In R&D Retool; Mini Labs Will Bid For Project Funding
Pfizer Unveils Oncology Business Unit, Gives Failed Compounds Another Try
Pfizer Unveils Oncology Business Unit, Gives Failed Compounds Another Try

Topics

Advertisement
UsernamePublicRestriction

Register

PS068337

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel